Abstract:Highlights • Glioblastoma is an aggressive brain tumor with high rate of recurrence. • Implantable biomaterials are promising approaches against glioblastoma relapse. • Soy protein hydrogels embedding drug-loaded liposomes were pioneering fabricated. • Varying soy protein amount and liposome size, a controlled release is achieved. • The liposomes released from hydrogels are intact and active on glioblastoma cells. Glioblastoma (GB) is the most common and aggressive brain tumor. The treatment for newly diagnosed glioblastoma is surgical resection of the primary tumor mass, followed by radiotherapy and chemotherapy. However, recurrences frequently occur in proximity to the surgical resection area. In these cases, none of the current therapies is effective. Recently, implantable biomaterials seem to be a promising strategy against GB recurrence. Here, for the first time we combined the tailorable properties of soy-protein hydrogels with the versatility of drug-loaded liposomes to realize a hybrid biomaterial for controlled and sustained nanoparticles release. Hydrogel consisting of 18–20 % w/v soy-protein isolated were fabricated in absence of chemical cross-linkers. They were biodegradable (−10 % and −30 % of weight by hydrolytic and enzymatic degradation, respectively in 3 days), biocompatible (>95 % of cell viability after treatment), and capable of sustained release of intact doxorubicin-loaded liposomes (diffusion coefficient between 10 −18 and 10 −19 m 2 s −1 ). A proof-of-concept in a "donut-like" 3D-bioprinted model shows that liposomes released by hydrogels were able to diffuse in a model with a complex extracellular matrix-like network and a 3D structural organization, targeting glioblastoma cells. The combination of nanoparticles' encapsulation capabilities with the hydrogels' structural support and controlled release properties will provide a powerful tool with high clinical relevance that could be applicable for the treatment of other cancers, realizing patient-specific interventions. Graphical abstract Scheme 1- Graphical Illustration of the proposed strategy to counteract GB recurrence. After surgical resection of the newly diagnosed GB, SPI hydrogel embedding drug-loaded liposomes will be implanted for the controlled release of nanomedicines. Download : Download high-res image (274KB) Download : Download full-size image

Effect of Chitosan on Alginate-Based Macroporous Hydrogels for the Capture of Glioblastoma Cancer Cells

Macroporous chitosan/alginate hydrogels crosslinked with genipin accumulate and retain glioblastoma cancer cells

Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors

Self-Cross-Linked Chitosan/Albumin-Bound Nanoparticle Hydrogel for Inhibition of Postsurgery Malignant Glioma Recurrence

A Composite Nanosystem as a Potential Tool for the Local Treatment of Glioblastoma: Chitosan-Coated Solid Lipid Nanoparticles Embedded in Electrospun Nanofibers

Injectable pH Thermo-Responsive Hydrogel Scaffold for Tumoricidal Neural Stem Cell Therapy for Glioblastoma Multiforme

The Inhibition of Glioma Growth in Vitro and in Vivo by a Chitosan/ellagic Acid Composite Biomaterial

Nanocomposite formulation for a sustained release of free drug and drug-loaded responsive nanoparticles: an approach for a local therapy of glioblastoma multiforme

An injectable in situ hydrogel platform for sustained drug release against glioblastoma

Fabrication and optimization of chitosan -g- m-PEG-NH 2 copolymer for advanced glioblastoma therapy using surface engineered lentinan loaded nanovesicles for nasal delivery

A thermo-responsive chemically crosslinked long-term-release chitosan hydrogel system increases the efficiency of synergy chemo-immunotherapy in treating brain tumors

Thermosensitive injectable fibrillar gels based on cellulose nanocrystals grafted with poly(N-isopropylacrylamide) as biocompatible brain implants

Crosslinked Chitosan-PEG Hydrogel for Culture of Human Glioblastoma Cell Spheroids and Drug Screening

Biodegradable SPI-based hydrogel for controlled release of nanomedicines: A potential approach against brain tumors recurrence

Doxorubicin-loaded liposome-like particles embedded in chitosan/hyaluronic acid-based hydrogels as a controlled drug release model for local treatment of glioblastoma

A Nanogel with Effective Blood-Brain Barrier Penetration Ability through Passive and Active Dual-Targeting Function

Effect of Gambogic Acid–Loaded Porous-Lipid/PLGA Microbubbles in Combination With Ultrasound-Triggered Microbubble Destruction on Human Glioma

Exth-28. Developing A Novel Injectable Immunotherapeutic Gel For Encapsulation Of Natural Killer Cells For Post-Surgical Glioblastoma Treatment

Chitosan-PLGA mucoadhesive nanoparticles for gemcitabine repurposing for glioblastoma therapy

Polymersomes for Sustained Delivery of a Chalcone Derivative Targeting Glioblastoma Cells

Hydrogel loading functionalized PAMAM/shRNA complex for postsurgical glioblastoma treatment